Accordingly, ADCC activity was evaluated using Calcein-loaded SKOV3 ovarian carcinoma target cells and human NK-92 effector cells stably expressing FcγRIIIa V158 (Fig. 6B). This evidence concerns the gene FCGR3A and ovarian carcinoma.